Ignite Creation Date:
2025-12-25 @ 1:47 AM
Ignite Modification Date:
2025-12-26 @ 12:05 AM
Study NCT ID:
NCT07059494
Status:
RECRUITING
Last Update Posted:
2025-11-04
First Post:
2025-06-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Atezolizumab and Bevacizumab in Combination With Y^90 Radioembolization in HCC for Liver Transplant
Sponsor:
Icahn School of Medicine at Mount Sinai
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2026-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-08-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-08-01
Completion Date Type:
ESTIMATED
First Submit Date:
2025-06-17
First Submit QC Date:
None
Study First Post Date:
2025-07-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-01
Last Update Post Date:
2025-11-04
Last Update Post Date Type:
ESTIMATED